Pancreatic Cancer Research

ResearcherIndiana University HealthNo recent work listed

Yunlong Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2699-626X; OpenAlex author ID A5100337355. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper

Papers 8

  1. Critical Role of Novel O-GlcNAcylation of S550 and S551 on the p65 Subunit of NF-κB in Pancreatic Cancer. Co-author DOI 10.3390/cancers15194742↗
  2. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin. Co-author DOI 10.1002/jcsm.12998↗
  3. Intron-Retention Neoantigen Load Predicts Favorable Prognosis in Pancreatic Cancer. Last author DOI 10.1200/cci.21.00124↗
  4. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. Co-author DOI 10.1084/jem.20190450↗
  5. Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways. Co-author DOI 10.3390/cancers13081975↗
  6. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy. Co-author DOI 10.1002/jcsm.12461↗
  7. Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemc… Co-author DOI 10.1002/1878-0261.12314↗
  8. Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer Metastasis. Co-author DOI 10.3390/cancers10110403↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Leonidas G. Koniaris · 4 shared papers, 2019–2022 · strength 0.44
  2. Teresa A Zimmers · 4 shared papers, 2019–2022 · strength 0.44
  3. Safi Shahda · 4 shared papers, 2018–2022 · strength 0.41
  4. Ashok Narasimhan · 3 shared papers, 2021–2022 · strength 0.36
  5. Xiaoling Zhong · 3 shared papers, 2019–2022 · strength 0.33
  6. Ahmad R. Safa · 1 shared paper, 2023 · strength 0.18
  7. Aishat Motolani · 1 shared paper, 2023 · strength 0.18
  8. Xiumei Huang · 1 shared paper, 2023 · strength 0.18
  9. Tao Lu · 1 shared paper, 2023 · strength 0.18
  10. Michael Garrett House · 2 shared papers, 2019–2021 · strength 0.18
  11. Nicholas Joseph Zyromski · 2 shared papers, 2019–2021 · strength 0.18
  12. Eugene P. Ceppa · 2 shared papers, 2019–2021 · strength 0.18
  13. Christian Max Schmidt · 2 shared papers, 2019–2021 · strength 0.18
  14. Chuanpeng Dong · 1 shared paper, 2022 · strength 0.17
  15. Xiongbin Lu · 1 shared paper, 2022 · strength 0.17
  16. Daenique H. A. Jengelley · 1 shared paper, 2021 · strength 0.11
  17. Joseph E. Rupert · 1 shared paper, 2021 · strength 0.11
  18. Joshua K. Kays · 1 shared paper, 2021 · strength 0.10
  19. Shaoxiong Chen · 1 shared paper, 2018 · strength 0.08
  20. Patrick G. Schweickert · 1 shared paper, 2018 · strength 0.08
  21. Yi Yang · 1 shared paper, 2018 · strength 0.08
  22. Dongsheng Gu · 1 shared paper, 2018 · strength 0.08
  23. Brad L. Jakubison · 1 shared paper, 2018 · strength 0.08
  24. Pamela Itkin‐Ansari · 1 shared paper, 2018 · strength 0.08
  25. Stephen F Konieczny · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.